Table 1

Patient baseline characteristics

All (N = 156)
Low-risk patients (N = 39)
Higher-risk patients (N = 117)
P
n (%) or median (interquartile range)
Age (y)* 74.0 (69.0; 79.8) 73.0 (68.0; 77.0) 75.0 (69.0; 80.0) .27 
Male sex 92 (59) 4 (10) 88 (75) <.01 
PE and/or proximal DVT 137 (88) 28 (72) 109 (93) <.01 
D-dimer (ng/ml) 1022 (607; 1755) 717 (410; 1016) 1161 (694; 1913) <.01 
BMI (kg/m2)* 27.5 (24.8; 30.5) 27.7 (24.9; 31.9) 27.5 (24.8; 30.4) .44 
Prior VTE 23 (15) 8 (21) 15 (13) .30 
Time since stopping AC (mo) 5.7 (4.9; 6.9) 5.9 (5.0; 7.6) 5.6 (4.7; 6.6) .20 
Duration of prior AC (mo) 6.3 (5.3; 7.1) 6.0 (4.1; 6.9) 6.4 (5.5; 7.2) .20 
All (N = 156)
Low-risk patients (N = 39)
Higher-risk patients (N = 117)
P
n (%) or median (interquartile range)
Age (y)* 74.0 (69.0; 79.8) 73.0 (68.0; 77.0) 75.0 (69.0; 80.0) .27 
Male sex 92 (59) 4 (10) 88 (75) <.01 
PE and/or proximal DVT 137 (88) 28 (72) 109 (93) <.01 
D-dimer (ng/ml) 1022 (607; 1755) 717 (410; 1016) 1161 (694; 1913) <.01 
BMI (kg/m2)* 27.5 (24.8; 30.5) 27.7 (24.9; 31.9) 27.5 (24.8; 30.4) .44 
Prior VTE 23 (15) 8 (21) 15 (13) .30 
Time since stopping AC (mo) 5.7 (4.9; 6.9) 5.9 (5.0; 7.6) 5.6 (4.7; 6.6) .20 
Duration of prior AC (mo) 6.3 (5.3; 7.1) 6.0 (4.1; 6.9) 6.4 (5.5; 7.2) .20 

BMI, body mass index.

*

At the time of the index VTE.

At 12 months after the index VTE.

Close Modal

or Create an Account

Close Modal
Close Modal